Zeiser R, Ringden O, Sadeghi B, Gonen-Yaacovi G, Segurado OG. Novel therapies for graft versus host disease with a focus on cell therapies. Front Immunol. 2023;14:1241068.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Malard F, Huang XJ, Sim JPY. Treatment and unmet needs in steroid-refractory acute graft-versus-host disease. Leukemia. 2020;34(5):1229–40.

Article  PubMed  PubMed Central  Google Scholar 

Bader P, Kuci Z, Bakhtiar S, Basu O, Bug G, Dennis M, et al. Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM). Bone Marrow Transplant. 2018;53(7):852–62.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Muroi K, Miyamura K, Okada M, Yamashita T, Murata M, Ishikawa T, et al. Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study. Int J Hematol. 2016;103(2):243–50.

Article  PubMed  CAS  Google Scholar 

Kebriaei P, Hayes J, Daly A, Uberti J, Marks DI, Soiffer R, et al. A phase 3 randomized study of remestemcel-L versus placebo added to second-line therapy in patients with steroid-refractory acute graft-versus-host disease. Biol Blood Marrow Transplant. 2020;26(5):835–44.

Article  PubMed  CAS  Google Scholar 

Kurtzberg J, Prockop S, Chaudhury S, Horn B, Nemecek E, Prasad V, et al. Study 275: updated expanded access program for remestemcel-L in steroid-refractory acute graft-versus-host disease in children. Biol Blood Marrow Transplant. 2020;26(5):855–64.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Soder RP, Dawn B, Weiss ML, Dunavin N, Weir S, Mitchell J, et al. A phase i study to evaluate two doses of Wharton’s jelly-derived mesenchymal stromal cells for the treatment of de novo high-risk or steroid-refractory acute graft versus host disease. Stem Cell Rev Rep. 2020;16(5):979–91.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Salmenniemi U, Itala-Remes M, Nystedt J, Putkonen M, Niittyvuopio R, Vettenranta K, et al. Good responses but high TRM in adult patients after MSC therapy for GvHD. Bone Marrow Transplant. 2017;52(4):606–8.

Article  PubMed  CAS  Google Scholar 

Murata M, Terakura S, Wake A, Miyao K, Ikegame K, Uchida N, et al. Off-the-shelf bone marrow-derived mesenchymal stem cell treatment for acute graft-versus-host disease: real-world evidence. Bone Marrow Transplant. 2021;56(10):2355–66.

Article  PubMed  Google Scholar 

von Dalowski F, Kramer M, Wermke M, Wehner R, Rollig C, Alakel N, et al. Mesenchymal stromal cells for treatment of acute steroid-refractory graft versus host disease: clinical responses and long-term outcome. Stem Cells. 2016;34(2):357–66.

Article  Google Scholar 

Wang W, Lei W, Jiang L, Gao S, Hu S, Zhao ZG, et al. Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment. J Transl Med. 2021;19(1):198.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wang F, Li Y, Wang B, Li J, Peng Z. The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials. Crit Care. 2023;27(1):31.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA. 2003;100(14):8407–11.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Spees JL, Lee RH, Gregory CA. Mechanisms of mesenchymal stem/stromal cell function. Stem Cell Res Ther. 2016;7(1):125.

Article  PubMed  PubMed Central  Google Scholar 

Panoskaltsis-Mortari A, Griese M, Madtes DK, Belperio JA, Haddad IY, Folz RJ, et al. An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome. Am J Respir Crit Care Med. 2011;183(9):1262–79.

Article  PubMed  PubMed Central  Google Scholar 

Dsouza K, Pywell C, Thannickal VJ. Late noninfectious pulmonary complications in hematopoietic stem cell transplantation. Oncol Crit Care. 2020:625–41.

Cengiz Seval G, Topcuoglu P, Demirer T. Current approach to non-infectious pulmonary complications of hematopoietic stem cell transplantation. Balkan Med J. 2018;35(2):131–40.

Article  PubMed  PubMed Central  Google Scholar 

Yanik GA, Grupp SA, Pulsipher MA, Levine JE, Schultz KR, Wall DA, et al. TNF-receptor inhibitor therapy for the treatment of children with idiopathic pneumonia syndrome. A joint Pediatric Blood and Marrow Transplant Consortium and Children's Oncology Group Study (ASCT0521). Biol Blood Marrow Transplant. 2015;21(1):67–73.

Raza K, Larsen T, Samaratunga N, Price AP, Meyer C, Matson A, et al. MSC therapy attenuates obliterative bronchiolitis after murine bone marrow transplant. PLoS One. 2014;9(10): e109034.

Article  PubMed  PubMed Central  Google Scholar 

Qiao SK, Ren HY, Shi YJ, Liu W. Allogeneic compact bone-derived mesenchymal stem cell transplantation attenuates the severity of idiopathic pneumonia syndrome in a murine bone marrow transplantation model. Cell Physiol Biochem. 2016;40(6):1656–69.

Article  PubMed  CAS  Google Scholar 

Cao M, Liu H, Dong Y, Liu W, Yu Z, Wang Q, et al. Mesenchymal stem cells alleviate idiopathic pneumonia syndrome by modulating T cell function through CCR2-CCL2 axis. Stem Cell Res Ther. 2021;12(1):378.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chambers DC, Enever D, Lawrence S, Sturm MJ, Herrmann R, Yerkovich S, et al. Mesenchymal stromal cell therapy for chronic lung allograft dysfunction: results of a first-in-man study. Stem Cells Transl Med. 2017;6(4):1152–7.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Laffey JG, Matthay MA. Fifty Years of Research in ARDS. Cell-based Therapy for acute respiratory distress syndrome. Biology and potential therapeutic value. Am J Respir Crit Care Med. 2017;196(3):266–73.

Cruz FF, Rocco PRM. Cell therapy for acute respiratory distress syndrome patients: the START study. J Thorac Dis. 2019;11(Suppl 9):S1329–32.

Article  PubMed  PubMed Central  Google Scholar 

Bellingan G, Jacono F, Bannard-Smith J, Brealey D, Meyer N, Thickett D, et al. Safety and efficacy of multipotent adult progenitor cells in acute respiratory distress syndrome (MUST-ARDS): a multicentre, randomised, double-blind, placebo-controlled phase 1/2 trial. Intensive Care Med. 2022;48(1):36–44.

Article  PubMed  CAS  Google Scholar 

Ringdén O, Solders M, Erkers T, Nava S, Molldén P, Hultcrantz M, et al. Successful reversal of acute lung injury using placenta-derived decidual stromal cells. J Stem Cell Res Ther. 2014;4(10):1–5.

Google Scholar 

Sadeghi B, Ringden O, Gustafsson B, Castegren M. Mesenchymal stromal cells as treatment for acute respiratory distress syndrome. Case Reports following hematopoietic cell transplantation and a review. Front Immunol. 2022;13:963445.

Moermans C, Lechanteur C, Baudoux E, Giet O, Henket M, Seidel L, et al. Impact of cotransplantation of mesenchymal stem cells on lung function after unrelated allogeneic hematopoietic stem cell transplantation following non-myeloablative conditioning. Transplantation. 2014;98(3):348–53.

Article  PubMed  Google Scholar 

Mohseni R, Mahdavi Sharif P, Behfar M, Modaresi MR, Shirzadi R, Mardani M, et al. Evaluation of safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells in pediatric bronchiolitis obliterans syndrome (BoS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Stem Cell Res Ther. 2023;14(1):256.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Qu Y, Yang X, Zhang X, Liu S, Liu X, Liu X, et al. Mesenchymal stromal cell treatment improves outcomes in children with pneumonia post-hematopoietic stem cell transplantation: a retrospective cohort study. Stem Cell Res Ther. 2022;13(1):277.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kambara Y, Fujii N, Usui Y, Yamamoto A, Higo H, Fujiwara H, et al. Association between early corticosteroid administration and long-term survival in non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2023;117(4):578–89.

Article  PubMed  CAS  Google Scholar 

Ho VT, Cutler C, Carter S, Martin P, Adams R, Horowitz M, et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11(8):571–5.

Article  PubMed